YJ001
AssetAlso YJ001 Spray
Topical spray formulated for diabetic peripheral neuropathic pain relief
- Stage
- Phase 3
- Modality
- Small molecule
- Target
- Not known
- 1
- Indication
- 2
- Trials
- 2
- Developers
Indications
1Diabetic peripheral neuropathic pain
Phase 3, Recruiting, NCT07859111, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Owner and partners2
- Trials2
- Competitors1
- Signals2
Every asset’s record: target, stage, trials and the evidence behind it.